Company intelligence / Profile preview

LifeCyte

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

LifeCyte is an early-stage biotechnology company focused on the intersection of longevity science and regenerative medicine. The company leverages advanced cellular reprogramming technologies to develop therapies aimed at reversing cellular aging and treating age-related degenerative diseases. By targeting fundamental biological drivers of aging, such as telomere attrition and epigenetic decay, LifeCyte seeks to restore youthful function to tissues and organs. Their platform integrates high-throughput screening with proprietary cell-based assays to identify novel therapeutic candidates. LifeCyte's mission is to extend human healthspan through the application of cutting-edge synthetic biology and regenerative therapeutics.

Therapeutic areas: Other
Modalities: Cell therapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on LifeCyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeCyte.

Explore the full profile